Amphastar Pharmaceuticals, Inc. (AMPH) investor relations documents from the company's IR site: 25 presentations; latest deck 2026-08-06. Read in-app with summaries. First-party data.
Presentations: Amphastar Pharmaceuticals is a vertically integrated specialty pharma company focused on proprietary peptides, biosimilars, and complex inhalation products.
| Published | Type | Document |
|---|---|---|
| 2026-08-06 | Presentation | Presentations |
| 2026-06-03 | Presentation | Presentations |
| 2026-05-13 | Presentation | Presentations |
| 2026-04-14 | Presentation | Presentations |
| 2026-03-11 | Presentation | Presentations |
| 2025-12-03 | Presentation | Presentations |
| 2025-08-07 | Presentation | Presentations |
| 2025-06-05 | Presentation | Presentations |
| 2025-05-14 | Presentation | Presentations |
| 2025-05-07 | Presentation | Presentations |
| 2025-04-09 | Presentation | Presentations |
| 2025-03-10 | Presentation | Presentations |
| 2025-02-27 | Presentation | Presentations |
| 2025-01-13 | Presentation | Presentations |
| 2024-12-04 | Presentation | Presentations |
| 2024-11-20 | Presentation | Presentations |
| 2024-11-08 | Presentation | Presentations |
| 2024-09-05 | Presentation | Presentations |
| 2024-06-06 | Presentation | Presentations |
| 2024-05-08 | Presentation | Presentations |
| 2022-11-29 | Presentation | Presentations |
| 2022-11-14 | Presentation | Presentations |
| 2022-06-08 | Presentation | Presentations |
| 2021-11-18 | Presentation | Presentations |
| 2021-11-18 | Presentation | Presentations |
AMPH overview · AMPH earnings · AMPH financials · AMPH KPIs · AMPH documents · AMPH ownership · AMPH peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.